Exploring Connections between Oral Microbiota, Short-Chain Fatty Acids, and Specific Cancer Types: A Study of Oral Cancer, Head and Neck Cancer, Pancreatic Cancer, and Gastric Cancer

Simple Summary Although there is strong evidence linking oral microbiota to several types of cancer, the causal connections between them remain controversial. This study aims to identify the common oral bacteria associated with various types of cancer and detect potential mechanisms underlying the oral microbiota that could activate immune responses and lead to the onset of cancer through cytokine secretion. We have confirmed that alterations in the composition of oral bacteria can contribute to a reduction in SCFAs and the expression of the FFAR 2, resulting in an inflammatory response through the upregulation of TNFAIP8 and the IL-6/STAT3 pathway, ultimately increasing the risk of cancer onset. These findings provide valuable insights into the potential role of the oral microbiome in cancer development and could pave the way for novel preventive and therapeutic strategies for cancer. Abstract The association between oral microbiota and cancer development has been a topic of intense research in recent years, with compelling evidence suggesting that the oral microbiome may play a significant role in cancer initiation and progression. However, the causal connections between the two remain a subject of debate, and the underlying mechanisms are not fully understood. In this case–control study, we aimed to identify common oral microbiota associated with several cancer types and investigate the potential mechanisms that may trigger immune responses and initiate cancer upon cytokine secretion. Saliva and blood samples were collected from 309 adult cancer patients and 745 healthy controls to analyze the oral microbiome and the mechanisms involved in cancer initiation. Machine learning techniques revealed that six bacterial genera were associated with cancer. The abundance of Leuconostoc, Streptococcus, Abiotrophia, and Prevotella was reduced in the cancer group, while abundance of Haemophilus and Neisseria enhanced. G protein-coupled receptor kinase, H+-transporting ATPase, and futalosine hydrolase were found significantly enriched in the cancer group. Total short-chain fatty acid (SCFAs) concentrations and free fatty acid receptor 2 (FFAR2) expression levels were greater in the control group when compared with the cancer group, while serum tumor necrosis factor alpha induced protein 8 (TNFAIP8), interleukin-6 (IL6), and signal transducer and activator of transcription 3 (STAT3) levels were higher in the cancer group when compared with the control group. These results suggested that the alterations in the composition of oral microbiota can contribute to a reduction in SCFAs and FFAR2 expression that may initiate an inflammatory response through the upregulation of TNFAIP8 and the IL-6/STAT3 pathway, which could ultimately increase the risk of cancer onset.

[1]  Yusuf Alan,et al.  Postbiotic metabolites, antioxidant and anticancer activities of probiotic Leuconostoc pseudomesenteroides strains in natural pickles , 2022, Archives of Microbiology.

[2]  Li V. Yang,et al.  Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications , 2022, Cells.

[3]  E. Franz,et al.  Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge , 2021, Frontiers in Microbiology.

[4]  D. Frank,et al.  A Dysbiotic Microbiome Promotes Head and Neck Squamous Cell Carcinoma , 2021, Oncogene.

[5]  T. Karpiński,et al.  The Oral Microbiota and its Role in Carcinogenesis. , 2021, Seminars in cancer biology.

[6]  M. Assafi,et al.  The association between body mass index and the oral Firmicutes and Bacteroidetes profiles of healthy individuals. , 2021, Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia.

[7]  A. Hackshaw,et al.  Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK , 2021, British Journal of Cancer.

[8]  A. A. Khan,et al.  Microbiota and cancer: current understanding and mechanistic implications , 2021, Clinical and Translational Oncology.

[9]  Xuefeng Gao,et al.  Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study , 2021, Frontiers in Cellular and Infection Microbiology.

[10]  S. Bakhti,et al.  Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next? , 2021, BMC microbiology.

[11]  H. Tuominen,et al.  Oral Microbiota and Cancer Development , 2020, Pathobiology.

[12]  Dae Hyun Lee,et al.  Abiotrophia and Granulicatella Infections in Cancer Patients: A Single-Center Chart Review Study , 2020, Journal of Microbiology and Infectious Diseases.

[13]  P. Ferrante,et al.  The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development , 2020, Microorganisms.

[14]  György Kovács,et al.  Smote-variants: A python implementation of 85 minority oversampling techniques , 2019, Neurocomputing.

[15]  György Kovács,et al.  An empirical comparison and evaluation of minority oversampling techniques on a large number of imbalanced datasets , 2019, Appl. Soft Comput..

[16]  Michael W. Kattan,et al.  A comprehensive data level analysis for cancer diagnosis on imbalanced data , 2019, J. Biomed. Informatics.

[17]  G. Sethi,et al.  Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression. , 2018, Cancer letters.

[18]  Yulong Yin,et al.  Implication of G Protein-Coupled Receptor 43 in Intestinal Inflammation: A Mini-Review , 2018, Front. Immunol..

[19]  Patrice D Cani,et al.  Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer , 2018, Nature Reviews Gastroenterology & Hepatology.

[20]  Zhongtao Zhang,et al.  A screening method for gastric cancer by oral microbiome detection. , 2018, Oncology reports.

[21]  R. Hayes,et al.  Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer , 2018, JAMA oncology.

[22]  Jennifer R. Grandis,et al.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.

[23]  A. Barzegari,et al.  Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Apolinaria García,et al.  Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. , 2016, Journal of medical microbiology.

[25]  R. Hayes,et al.  Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study , 2016, Gut.

[26]  Shuwen Han,et al.  Potential screening and early diagnosis method for cancer: Tongue diagnosis , 2016, International journal of oncology.

[27]  Ya-Wen Gou,et al.  Association between alcohol intake and the risk of pancreatic cancer: a dose–response meta-analysis of cohort studies , 2016, BMC Cancer.

[28]  Hongwei Cheng,et al.  Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China , 2015, PloS one.

[29]  A. Ichimura,et al.  Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation , 2015, Nutrients.

[30]  Adam B. Olshen,et al.  Changes in Abundance of Oral Microbiota Associated with Oral Cancer , 2014, PloS one.

[31]  R. Lamont,et al.  Oral Bacteria and Cancer , 2014, PLoS pathogens.

[32]  A. Astrup,et al.  Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases? , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[33]  D. Devine,et al.  Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics , 2013, Clinical, cosmetic and investigational dentistry.

[34]  G. Ginsburg,et al.  The oral microbiome in health and disease and the potential impact on personalized dental medicine. , 2012, Oral diseases.

[35]  R. Hafidh,et al.  The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role , 2011, Journal of experimental & clinical cancer research : CR.

[36]  P. Chaturvedi,et al.  The role of bacteria in oral cancer , 2010, Indian Journal of Medical and Paediatric Oncology.

[37]  G. Cresci,et al.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.

[38]  M. Posner,et al.  The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.

[39]  S. Kimura,et al.  Streptococcus anginosus infection in oral cancer and its infection route. , 2005, Oral diseases.

[40]  N. Hanada,et al.  Molecular analysis of age-related changes of Streptococcus anginosus group and Streptococcus mitis in saliva. , 2004, Oral microbiology and immunology.

[41]  B. Evers,et al.  Butyrate inhibits pancreatic cancer invasion , 2003, Journal of Gastrointestinal Surgery.

[42]  N. Weiss,et al.  An exploration of the periodontitis-cancer association. , 2003, Annals of epidemiology.

[43]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[44]  G. Corrao,et al.  A meta-analysis of alcohol drinking and cancer risk , 2001, British Journal of Cancer.

[45]  Y. Nakanishi,et al.  Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. , 1998, Cancer research.

[46]  H. Newman,et al.  The microflora associated with human oral carcinomas. , 1998, Oral oncology.

[47]  P. Holmstrup,et al.  Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. , 1987, Carcinogenesis.

[48]  Ruth Etzioni,et al.  Early detection: The case for early detection , 2003, Nature Reviews Cancer.

[49]  H. Ludwig,et al.  Interleukin-6 is a prognostic factor in multiple myeloma. , 1991, Blood.